Choline transporter mutations in severe congenital myasthenic syndrome disrupt transporter localization
 
Yazarlar (1)
Doç. Dr. Uğur AKPULAT Kastamonu Üniversitesi, Türkiye
Makale Türü Açık Erişim Özgün Makale (SSCI, AHCI, SCI, SCI-Exp dergilerinde yayınlanan tam makale)
Dergi Adı Brain (Q1)
Dergi ISSN 0006-8950 Wos Dergi Scopus Dergi
Dergi Tarandığı Indeksler SCI-Expanded
Makale Dili İngilizce Basım Tarihi 10-2017
Cilt / Sayı / Sayfa 140 / 11 / 2838–2850 DOI 10.1093/brain/awx249
Makale Linki https://doi.org/10.1093/brain/awx249
UAK Araştırma Alanları
Tıbbi Biyoloji
Özet
The presynaptic, high-affinity choline transporter is a critical determinant of signalling by the neurotransmitter acetylcholine at both central and peripheral cholinergic synapses, including the neuromuscular junction. Here we describe an autosomal recessive presynaptic congenital myasthenic syndrome presenting with a broad clinical phenotype due to homozygous choline transporter missense mutations. The clinical phenotype ranges from the classical presentation of a congenital myasthenic syndrome in one patient (p.Pro210Leu), to severe neurodevelopmental delay with brain atrophy (p.Ser94Arg) and extend the clinical outcomes to a more severe spectrum with infantile lethality (p.Val112Glu). Cells transfected with mutant transporter construct revealed a virtually complete loss of transport activity that was paralleled by a reduction in transporter cell surface expression. Consistent with these findings …
Anahtar Kelimeler
choline uptake | CHT | CHT trafficking | congenital myasthenic syndrome | SLC5A7
BM Sürdürülebilir Kalkınma Amaçları
Atıf Sayıları
Web of Science 26
Scopus 29
Google Scholar 37
Choline transporter mutations in severe congenital myasthenic syndrome disrupt transporter localization

Paylaş